{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:40:50Z","timestamp":1789026050196,"version":"build-2803163510"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173822"],"award-info":[{"award-number":["82173822"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Ulcerative colitis (UC) is characterized by a complicated interaction between mucosal inflammation, epithelial dysfunction, abnormal activation of innate immune responses, and gut microbiota dysbiosis. Though valeric acid (VA), one type of short-chain fatty acids (SCFAs), has been identified in other inflammatory disorders and cancer development, the pathological role of VA and underlying mechanism of VA in UC remain under further investigation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Studies of human clinical specimens and experimental colitis models were conducted to confirm the pathological manifestations of the level of SCFAs from human fecal samples and murine colonic homogenates. Valeric acid\u2013intervened murine colitis and a macrophage adoptive transfer were applied to identify the underlying mechanisms.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In line with gut microbiota dysfunction in UC, alteration of SCFAs from gut microbes were identified in human UC patients and dextran sodium sulfate \u2013induced murine colitis models. Notably, VA was consistently negatively related to the disease severity of UC, the population of monocytes, and the level of interluekin-6. Moreover, VA treatment showed direct suppressive effects on lipopolysaccharides (LPS)-activated human peripheral blood mononuclear cells and murine macrophages in the dependent manner of upregulation of GPR41 and GPR43. Therapeutically, replenishment of VA or adoptive transfer with VA-modulated macrophages showed resistance to dextran sodium sulfate\u2013driven murine colitis though modulating the production of inflammatory cytokine interleukin-6.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In summary, the research uncovered the pathological role of VA in modulating the activation of macrophages in UC and suggested that VA might be a potential effective agent for UC patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ibd\/izad187","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T15:53:57Z","timestamp":1704988437000},"page":"617-628","source":"Crossref","is-referenced-by-count":39,"title":["Revisiting the Role of Valeric Acid in Manipulating Ulcerative Colitis"],"prefix":"10.1093","volume":"30","author":[{"given":"Moting","family":"Liu","sequence":"first","affiliation":[{"name":"Laboratory of Anti-inflammation and Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203 , China"},{"name":"School of Pharmacy, University of Chinese Academy of Sciences , Beijing 100049 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine , Shanghai 200025 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[{"name":"Institutional Technology Service Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai, 201203 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caigui","family":"Xiang","sequence":"additional","affiliation":[{"name":"Laboratory of Anti-inflammation and Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203 , China"},{"name":"School of Pharmacy, University of Chinese Academy of Sciences , Beijing 100049 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiukai","family":"Lu","sequence":"additional","affiliation":[{"name":"Laboratory of Anti-inflammation and Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203 , China"},{"name":"School of Pharmacy, University of Chinese Academy of Sciences , Beijing 100049 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Lu","sequence":"additional","affiliation":[{"name":"Laboratory of Anti-inflammation and Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203 , China"},{"name":"School of Pharmacy, University of Chinese Academy of Sciences , Beijing 100049 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[{"name":"Laboratory of Anti-inflammation and Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203 , China"},{"name":"School of Pharmacy, University of Chinese Academy of Sciences , Beijing 100049 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Wang","sequence":"additional","affiliation":[{"name":"Laboratory of Anti-inflammation and Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203 , China"},{"name":"School of Pharmacy, University of Chinese Academy of Sciences , Beijing 100049 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingli","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institutional Technology Service Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai, 201203 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Fan","sequence":"additional","affiliation":[{"name":"Laboratory of Anti-inflammation and Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlan","family":"Feng","sequence":"additional","affiliation":[{"name":"Laboratory of Anti-inflammation and Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duowu","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine , Shanghai 200025 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4997-671X","authenticated-orcid":false,"given":"Heng","family":"Li","sequence":"additional","affiliation":[{"name":"Laboratory of Anti-inflammation and Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2662-217X","authenticated-orcid":false,"given":"Wei","family":"Tang","sequence":"additional","affiliation":[{"name":"Laboratory of Anti-inflammation and Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203 , China"},{"name":"School of Pharmacy, University of Chinese Academy of Sciences , Beijing 100049 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"issue":"21","key":"2024040305541326100_CIT0001","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"MECHANISMS OF DISEASE inflammatory bowel disease","volume":"361","author":"Abraham","year":"2009","journal-title":"New Engl J Med"},{"issue":"9573","key":"2024040305541326100_CIT0002","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(07)60750-8","article-title":"Inflammatory bowel disease: cause and immunobiology","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"issue":"12","key":"2024040305541326100_CIT0003","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD: from 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"1","key":"2024040305541326100_CIT0004","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology."},{"issue":"1","key":"2024040305541326100_CIT0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","article-title":"Immunopathogenesis of IBD: current state of the art","volume":"13","author":"de Souza","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6289","key":"2024040305541326100_CIT0006","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1126\/science.aad9948","article-title":"Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease","volume":"352","author":"Chu","year":"2016","journal-title":"Science."},{"issue":"1","key":"2024040305541326100_CIT0007","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12967-019-02174-1","article-title":"Integrating omics for a better understanding of inflammatory bowel disease: a step towards personalized medicine","volume":"17","author":"Kumar","year":"2019","journal-title":"J Transl Med."},{"issue":"10","key":"2024040305541326100_CIT0008","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrgastro.2012.152","article-title":"The gut microbiota in IBD","volume":"9","author":"Manichanh","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"2024040305541326100_CIT0009","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41579-020-0367-2","article-title":"Host-microbiota interactions in immune-mediated diseases","volume":"18","author":"Ruff","year":"2020","journal-title":"Nat Rev Microbiol."},{"issue":"7415","key":"2024040305541326100_CIT0010","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature11550","article-title":"Diversity, stability and resilience of the human gut microbiota","volume":"489","author":"Lozupone","year":"2012","journal-title":"Nature."},{"issue":"7610","key":"2024040305541326100_CIT0011","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature18848","article-title":"The microbiota in adaptive immune homeostasis and disease","volume":"535","author":"Honda","year":"2016","journal-title":"Nature."},{"issue":"10080","key":"2024040305541326100_CIT0012","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"2024040305541326100_CIT0013","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","article-title":"The microbiome in inflammatory bowel disease: current status and the future ahead","volume":"146","author":"Kostic","year":"2014","journal-title":"Gastroenterology."},{"issue":"2","key":"2024040305541326100_CIT0014","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","article-title":"Gut microbiome structure and metabolic activity in inflammatory bowel disease","volume":"4","author":"Franzosa","year":"2019","journal-title":"Nat Microbiol."},{"issue":"6252","key":"2024040305541326100_CIT0015","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1126\/science.aac4812","article-title":"Growth dynamics of gut microbiota in health and disease inferred from single metagenomic samples","volume":"349","author":"Korem","year":"2015","journal-title":"Science."},{"issue":"4","key":"2024040305541326100_CIT0016","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cmet.2020.09.004","article-title":"The gut microbiota at the service of immunometabolism","volume":"32","author":"Michaudel","year":"2020","journal-title":"Cell Metab."},{"issue":"8","key":"2024040305541326100_CIT0017","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3390\/nu11081712","article-title":"Gut microbiota-derived components and metabolites in the progression of non-alcoholic fatty liver disease (NAFLD)","volume":"11","author":"Ji","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"2024040305541326100_CIT0018","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1038\/s41467-018-06048-w","article-title":"Microbial metabolite sensor GPR43 controls severity of experimental GVHD","volume":"9","author":"Fujiwara","year":"2018","journal-title":"Nat Commun."},{"issue":"1","key":"2024040305541326100_CIT0019","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease","volume":"19","author":"Fan","year":"2020","journal-title":"Nat Rev Microbiol."},{"issue":"1","key":"2024040305541326100_CIT0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/apt.14689","article-title":"Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders","volume":"48","author":"Gill","year":"2018","journal-title":"Aliment Pharmacol Ther."},{"issue":"6","key":"2024040305541326100_CIT0021","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell."},{"issue":"1","key":"2024040305541326100_CIT0022","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1038\/ncomms7734","article-title":"Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome","volume":"6","author":"Macia","year":"2015","journal-title":"Nat Commun."},{"issue":"1","key":"2024040305541326100_CIT0023","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1152\/physrev.00041.2018","article-title":"Free fatty acid receptors in health and disease","volume":"100","author":"Kimura","year":"2020","journal-title":"Physiol Rev."},{"issue":"8","key":"2024040305541326100_CIT0024","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3390\/nu11081943","article-title":"The short-chain fatty acid acetate in body weight control and insulin sensitivity","volume":"11","author":"Hernandez","year":"2019","journal-title":"Nutrients"},{"issue":"2","key":"2024040305541326100_CIT0025","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.appet.2011.01.016","article-title":"Propionate. Anti-obesity and satiety enhancing factor","volume":"56","author":"Arora","year":"2011","journal-title":"Appetite."},{"key":"2024040305541326100_CIT0026","doi-asserted-by":"crossref","first-page":"909436","DOI":"10.3389\/fneur.2022.909436","article-title":"Short chain fatty acids protect the cognitive function of sepsis associated encephalopathy mice via GPR43","volume":"13","author":"Liao","year":"2022","journal-title":"Front Neurol."},{"issue":"1","key":"2024040305541326100_CIT0027","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12964-022-00869-5","article-title":"Regulatory role of short-chain fatty acids in inflammatory bowel disease","volume":"20","author":"Zhang","year":"2022","journal-title":"Cell Commun Signal"},{"issue":"8","key":"2024040305541326100_CIT0028","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41579-019-0213-6","article-title":"Microbial genes and pathways in inflammatory bowel disease","volume":"17","author":"Schirmer","year":"2019","journal-title":"Nat Rev Microbiol."},{"issue":"9","key":"2024040305541326100_CIT0029","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1021\/pr2003598","article-title":"Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome","volume":"10","author":"Le Gall","year":"2011","journal-title":"J Proteome Res."},{"issue":"1","key":"2024040305541326100_CIT0030","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1038\/s41598-021-81620-x","article-title":"Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications","volume":"11","author":"Shi","year":"2021","journal-title":"Sci Rep."},{"key":"2024040305541326100_CIT0031","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.omto.2020.08.017","article-title":"Valeric acid suppresses liver cancer development by acting as a novel HDAC inhibitor","volume":"19","author":"Han","year":"2020","journal-title":"Mol Ther Oncolytics."},{"issue":"4","key":"2024040305541326100_CIT0032","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/19490976.2019.1709387","article-title":"Gut commensal derived-valeric acid protects against radiation injuries","volume":"11","author":"Li","year":"2020","journal-title":"Gut Microbes"},{"issue":"4","key":"2024040305541326100_CIT0033","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41419-020-2470-8","article-title":"Intervention of oncostatin M-driven mucosal inflammation by berberine exerts therapeutic property in chronic ulcerative colitis","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis"},{"issue":"13","key":"2024040305541326100_CIT0034","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1111\/bph.14667","article-title":"Inhibition of phosphodiesterase-4 attenuates murine ulcerative colitis through interference with mucosal immunity","volume":"176","author":"Li","year":"2019","journal-title":"Br J Pharmacol."},{"issue":"9","key":"2024040305541326100_CIT0035","doi-asserted-by":"crossref","first-page":"e8730","DOI":"10.1002\/rcm.8730","article-title":"A rapid and convenient derivatization method for quantitation of short-chain fatty acids in human feces by ultra-performance liquid chromatography\/tandem mass spectrometry","volume":"34","author":"Fu","year":"2020","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"7858","key":"2024040305541326100_CIT0036","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41586-021-03484-5","article-title":"A myeloid-stromal niche and gp130 rescue in NOD2-driven Crohn\u2019s disease","volume":"593","author":"Nayar","year":"2021","journal-title":"Nature."},{"key":"2024040305541326100_CIT0037","doi-asserted-by":"crossref","first-page":"113958","DOI":"10.1016\/j.bcp.2020.113958","article-title":"DC591017, a phosphodiesterase-4 (PDE4) inhibitor with robust anti-inflammation through regulating PKA-CREB signaling","volume":"177","author":"Li","year":"2020","journal-title":"Biochem Pharmacol."},{"issue":"1","key":"2024040305541326100_CIT0038","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.apsb.2021.04.007","article-title":"Targeting PDE4 as a promising therapeutic strategy in chronic ulcerative colitis through modulating mucosal homeostasis","volume":"12","author":"Li","year":"2021","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"10","key":"2024040305541326100_CIT0039","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.3390\/nu12103054","article-title":"Involvement of gut microbiota, microbial metabolites and interaction with polyphenol in host immunometabolism","volume":"12","author":"Man","year":"2020","journal-title":"Nutrients"},{"issue":"6","key":"2024040305541326100_CIT0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nri.2016.42","article-title":"Gut microbiota, metabolites and host immunity","volume":"16","author":"Rooks","year":"2016","journal-title":"Nat Rev Immunol."},{"key":"2024040305541326100_CIT0041","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","article-title":"Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases","volume":"10","author":"Parada Venegas","year":"2019","journal-title":"Front Immunol."},{"issue":"3","key":"2024040305541326100_CIT0042","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","article-title":"Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism","volume":"7","author":"Morrison","year":"2016","journal-title":"Gut Microbes"},{"issue":"7","key":"2024040305541326100_CIT0043","doi-asserted-by":"crossref","first-page":"e0201073","DOI":"10.1371\/journal.pone.0201073","article-title":"Human gut bacteria as potent class I histone deacetylase inhibitors in vitro through production of butyric acid and valeric acid","volume":"13","author":"Yuille","year":"2018","journal-title":"PLoS One."},{"issue":"5","key":"2024040305541326100_CIT0044","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s41423-020-00625-0","article-title":"Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids","volume":"18","author":"Kim","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"2024040305541326100_CIT0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00535-016-1242-9","article-title":"Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases","volume":"52","author":"Sun","year":"2017","journal-title":"J Gastroenterol."},{"issue":"2","key":"2024040305541326100_CIT0046","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bbrc.2017.03.071","article-title":"Short-chain fatty acids, GPR41 and GPR43 ligands, inhibit TNF-alpha-induced MCP-1 expression by modulating p38 and JNK signaling pathways in human renal cortical epithelial cells","volume":"486","author":"Kobayashi","year":"2017","journal-title":"Biochem Biophys Res Commun."},{"issue":"6","key":"2024040305541326100_CIT0047","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res."},{"issue":"3","key":"2024040305541326100_CIT0048","first-page":"266","article-title":"Role of bile acids in inflammatory bowel disease","volume":"31","author":"Tiratterra","year":"2018","journal-title":"Ann Gastroenterol"},{"key":"2024040305541326100_CIT0049","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.trsl.2020.08.007","article-title":"TMAO: how gut microbiota contributes to heart failure","volume":"228","author":"Zhang","year":"2021","journal-title":"Transl Res"},{"issue":"3","key":"2024040305541326100_CIT0050","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/advances\/nmz127","article-title":"Tryptophan metabolism: a link between the gut microbiota and brain","volume":"11","author":"Gao","year":"2020","journal-title":"Adv Nutr."},{"issue":"7919","key":"2024040305541326100_CIT0051","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41586-022-04884-x","article-title":"The gut metabolite indole-3 propionate promotes nerve regeneration and repair","volume":"607","author":"Serger","year":"2022","journal-title":"Nature."},{"issue":"20","key":"2024040305541326100_CIT0052","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1007\/s00018-019-03190-6","article-title":"Bridging intestinal immunity and gut microbiota by metabolites","volume":"76","author":"Wang","year":"2019","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"2024040305541326100_CIT0053","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3748\/wjg.v22.i3.895","article-title":"Diet and nutritional factors in inflammatory bowel diseases","volume":"22","author":"Owczarek","year":"2016","journal-title":"World J Gastroenterol."},{"issue":"5","key":"2024040305541326100_CIT0054","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/ni.3713","article-title":"Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes","volume":"18","author":"Marino","year":"2017","journal-title":"Nat Immunol."},{"issue":"7480","key":"2024040305541326100_CIT0055","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature."},{"issue":"6","key":"2024040305541326100_CIT0056","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.cell.2020.02.035","article-title":"Propionic acid shapes the multiple sclerosis disease course by an immunomodulatory mechanism","volume":"180","author":"Duscha","year":"2020","journal-title":"Cell."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izad187\/55447507\/izad187.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/30\/4\/617\/57050082\/izad187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/30\/4\/617\/57050082\/izad187.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T05:55:59Z","timestamp":1712123759000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/30\/4\/617\/7516361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":56,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,1,11]]},"published-print":{"date-parts":[[2024,4,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izad187","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4,1]]},"published":{"date-parts":[[2024,1,11]]}}}